End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1.74 USD | 0.00% | +1.75% | -7.94% |
Feb. 22 | Notable Labs, Ltd. Advances Volasertib Phase 2 Program Utilizing Proprietary Predictive Precision Medicine Platform-Guided Enrollment | CI |
Jan. 09 | Top Premarket Gainers | MT |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
- Stock
- Equities
- Stock Notable Labs, Ltd. - Nasdaq
- Revisions Notable Labs, Ltd.